Michael O. Idowu

Michael O. Idowu

Auto-generated profile, based on publicly available information

Michael O. Idowu

Department of Pathology, Virginia Commonwealth University, Richmond, Virginia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Human Pathology
Verified
Journal Article
Closed access
MIMichael O. Idowu
Michael O. Idowu
MKMaciej Kmieciak
Maciej Kmieciak
CDCatherine Dumur
Catherine Dumur
RBRegina S. Burton
Regina S. Burton
MGMargaret M. Grimes
Margaret M. Grimes
MMMasoud H. Manjili
Masoud H. Manjili

1 July 2012 in Cancer Biology & Therapy
Verified
Journal Article
Open access
PDF file
MZMin Zhao
Min Zhao
PSPatrick Sachs
Patrick Sachs
XWXu Wang
Xu Wang
CDCatherine I. Dumur
Catherine I. Dumur
MIMichael O. Idowu
Michael O. Idowu
LELynne W. Elmore
Lynne W. Elmore
Data are accumulating to support a role for adipose-derived mesenchymal stem cells (MSCs) in breast cancer progression; however, to date most studies have relied on adipose MSCs from non-breast sources. There is a particular need to investigate the role of adipose MSCs in the pathogenesis of basal-like breast cancer, which develops at a disproportionate rate in pre-menopausal African-American women with a gain in adiposity. The aim of this study was to better understand how breast adipose MSCs (bMSCs) contribute to the progression of basal-like breast cancers by relying on isogenic HMT-3255 S3 (pre-invasive) and T4-2 (invasive) human cells that upon transplantation into nude mice resemble this tumor subtype. In vitro results suggested that bMSCs may contribute to breast cancer progression in multiple ways. bMSCs readily penetrate extracellular matrix components in part through their expression of matrix metalloproteinases 1 and 3, promote the invasion of T4-2 cells and efficiently chemoattract endothelial cells via a bFGF-independent, VEGF-A-dependent manner. As mixed xenografts, bMSCs stimulated the growth, invasion and desmoplasia of T4-2 tumors, yet these resident stem cells showed no observable effect on the progression of pre-invasive S3 cells. While bMSCs form vessel-like structures within Matrigel both in vitro and in vivo and chemoattract endothelial cells, there appeared to be no difference between T4-2/bMSC mixed xenografts and T4-2 xenografts with regard to intra- or peri-tumoral vascularity. Collectively, our data suggest that bMSCs may contribute to the progression of basal-like breast cancers by stimulating growth and invasion but not vasculogenesis or angiogenesis.

1 August 2011 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
RNRaouf E Nakhleh
Raouf E Nakhleh
MIMichael O Idowu
Michael O Idowu
RSRhona J. Souers
Rhona J. Souers
FMFrederick A Meier
Frederick A Meier
LBLeonas G. Bekeris
Leonas G. Bekeris
Context .—Accurate specimen labeling is a major patient-safety initiative by the Joint Commission and the College of American Pathologists. Inadequate specimen labels have led to patient injury from wrong patient diagnosis, wrong side treatment, and delay in diagnosis. Objectives .—To quantify the rates of mislabeled cases, specimens, blocks, and slides and to identify the sources of error and the ways in which errors are detected. Design .—In this voluntary-subscription Q-Probes study, participants prospectively reviewed surgical pathology cases for 8 weeks or until 30 errors (mislabeled cases, specimens, blocks, and slides) were identified. Information collected on each labeling error included the work location where the defect occurred, what was mislabeled, the number of items affected, the point of detection, and the consequences of the mislabeling error, along with institutional demographics and practice. The rates of mislabeled cases, specimens, blocks, and slides were tested for association with institutional demographics and practice variables. Results .—Of the 136 institutions providing information on a total of 1811 mislabeling occurrences, the overall mislabeling rates per 1000 were 1.1 cases, 1.0 specimen, 1.7 blocks, and 1.1 slides. Of all mislabeling events, 27.1% were cases, 19.8% specimens, 25.5% blocks, and 27.7% slides. The work locations at which the errors occurred were 20.9% before accessioning, 12.4% at accessioning, 21.7% at block labeling, 10.2% during gross pathology, and 30.4% at tissue cutting. Errors were typically detected in the first or second steps immediately following the error. Lower mislabeled slide rates were associated with continuous individual case accessioning and use of formal checks at accessioning. Routinely including a statement in the gross description that the specimen is labeled with the patient's name and is properly identified was also associated with lower rates of specimen mislabeling. The errors were corrected before reports were issued 96.7% of the time; for 3.2% of errors, a corrected report was issued. In 1.3% of error occurrences, participants gauged that patient care was affected. Conclusions .—This study quantified mislabeling rates across 136 institutions of cases (0.11%), specimens (0.1%), blocks (0.17%), and slides (0.11%). Errors in labeling appear nearly equally throughout the system of accessioning, gross pathology processing, and tissue cutting. Errors are typically detected in the immediate steps after the errors occurred, reinforcing the need for quality checks throughout the system.

1 January 2012 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
MIMichael O Idowu
Michael O Idowu
LHLinday Bonner Hardy
Linday Bonner Hardy
RSRhona J. Souers
Rhona J. Souers
RNRaouf E Nakhleh
Raouf E Nakhleh
Context .—Correlation of radiologic and pathologic findings is important for optimal management of patients with image-guided breast biopsies. Objectives .—To (1) evaluate the rates of radiologic and pathologic correlation in breast needle core biopsies, (2) evaluate laboratory and radiology practices associated with greater correlation rates, and (3) determine the rates at which the lack of radiologic-pathologic correlation is documented in pathology reports. Design .—The study was offered and conducted as a College of American Pathologists voluntary Q-Probes program. Participants in this study retrospectively reviewed 30 consecutive, initial, diagnostic needle core biopsy cases performed for abnormal radiologic findings. If 12 months of accessioned cases were reviewed without identifying 30 qualifying cases, participants stopped the retrospective review and included all cases identified. For each case or specimen, the participants provided detailed information about the radiologic and pathologic findings. Results .—In aggregate, a radiologic-pathologic correlation was found in 94.9% (1328 of 1399) of the cases reviewed, based on the participants' judgments. Significant differences in the correlation rates existed when cases were discussed at an interdepartmental, multidisciplinary conference ( P < .001). No significant differences were found in the correlation rates of the following: whether surgeons or radiologists performed the biopsy, whether cores with calcifications were identified by any method, and whether the laboratory had one or more designated breast pathologists. Conclusions .—Participation in a multidisciplinary breast conference is useful in radiologic-pathologic correlation. Active involvement by pathologists in correlating pathologic and radiologic findings is important.

15 October 2009 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
MDMalissa C. Diehl
Malissa C. Diehl
MIMichael O. Idowu
Michael O. Idowu
KKKatherine Kimmelshue
Katherine Kimmelshue
TYTimothy P. York
Timothy P. York
LELynne W. Elmore
Lynne W. Elmore
SHShawn E. Holt
Shawn E. Holt
With the current trend for early breast cancer detection, there is also a growing demand for discovering markers to assist in the patient risk stratification. Molecular chaperones play essential ro...

1 April 2002 in Hematology/Oncology Clinics of North America
Verified
Journal Article
Closed access
RRRoger S Riley
Roger S Riley
DMDavis Massey
Davis Massey
CJColleen Jackson-Cook
Colleen Jackson-Cook
MIMichael Idowu
Michael Idowu
GRGina Romagnoli
Gina Romagnoli